
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: June 5, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: June 5, 2024
Language: Английский
International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(17), P. 9588 - 9588
Published: Sept. 4, 2024
Even though several highly effective treatments have been developed for multiple sclerosis (MS), the underlying pathological mechanisms and drivers of disease not fully elucidated. In recent years, there has a growing interest in studying neuroinflammation context glial cell involvement as is increasing evidence their central role progression. Although communication proper function underlies brain homeostasis maintenance, effects an MS remain complex controversial. this review, we aim to provide overview contribution cells, oligodendrocytes, astrocytes, microglia pathology during both activation orchestration inflammatory mechanisms, well synergistic repair restoration function. Additionally, discuss how understanding may new therapeutic targets either limit progression or facilitate repair.
Language: Английский
Citations
8Molecular Neurodegeneration, Journal Year: 2024, Volume and Issue: 19(1)
Published: July 12, 2024
Multiple sclerosis (MS) therapeutic goals have traditionally been dichotomized into two distinct avenues: immune-modulatory-centric interventions and pro-regenerative strategies. Oligodendrocyte progenitor cells (OPCs) were regarded for many years solely in concern to their potential generate oligodendrocytes myelin the central nervous system (CNS). However, accumulating data elucidate multifaceted roles of OPCs, including immunomodulatory functions, positioning them as cardinal constituents CNS's immune landscape.
Language: Английский
Citations
7Neurology International, Journal Year: 2025, Volume and Issue: 17(1), P. 6 - 6
Published: Jan. 13, 2025
Neuroinflammation is a blanket term that describes the body’s complex inflammatory response in central nervous system (CNS). It encompasses phenotype shift to proinflammatory state, release of cytokines, recruitment peripheral immune cells, and wide variety other processes. has been implicated nearly every major CNS disease ranging from Alzheimer’s brain cancer. Understanding modeling neuroinflammation critical for identification novel therapeutic targets treatment diseases. Unfortunately, translation findings non-human models left much be desired. This review systematically discusses role human pluripotent stem cell (hPSC)-derived glia supporting cells within CNS, including astrocytes, microglia, oligodendrocyte precursor pericytes, endothelial describe state field hope future discoveries. hPSC-derived offer an expanded potential study pathobiology immunomodulatory cascades impact progression. While progress made development models, there explore application these understand CNS.
Language: Английский
Citations
0Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15
Published: July 9, 2024
Oligodendrocyte precursor cells (OPCs) have long been regarded as progenitors of oligodendrocytes, yet recent advances illuminated their multifaceted nature including emerging immune functions. This review seeks to shed light on the functions exhibited by OPCs, spanning from phagocytosis modulation and direct engagement with across various pathological scenarios. Comprehensive understanding OPCs alongside other roles will pave way for targeted therapies in neurological disorders.
Language: Английский
Citations
3Aging, Journal Year: 2024, Volume and Issue: 16(17), P. 12335 - 12345
Published: Aug. 28, 2024
Objective: To investigate the effect of PD-1 monoclonal antibodies in tumor-associated macrophages on angiogenesis cervical cancer and its mechanism action. Methods: The progression was assessed using nude mouse xenograft model HE staining; impact cell migration evaluated wound healing assay Transwell assay; vascular formation cells examined an expression related proteins tested Western blotting. Results: can regulate thus inhibit while promoting SHP2. Additionally, Sindilizumab inhibited tissue-type fibrinogen activator K HIF1α through PD-1/IRE1α/SHP2 signaling pathway, which neovascularization cells. Conclusions: This study discovered that generation inside by affecting PD-1/IRE1α/SHP2/HIF1α providing a new therapeutic target for treatment cancer.
Language: Английский
Citations
0bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 17, 2024
Abstract Background and Objectives Oligodendrocytes (OL) their myelin-forming processes are targeted lost during the disease course of Multiple Sclerosis (MS), by infiltrating leukocytes effector cytokines. Myelin repair is considered to be dependent on recruitment differentiation oligodendrocyte precursor cells (OPCs). The basis failure re-myelination MS remains defined. aim this study determine impact pro-inflammatory molecules tumor necrosis factor ⍰ (TNF⍰) interferon gamma (IFN γ ) human OPCs. Methods We generated OPCs from induced pluripotent stem with a reporter gene under OL-specific transcription SOX10. treated in vitro TNF⍰ or IFN evaluated effects terms cell viability, expression OL-lineage markers, co- astrocyte markers. To relate our findings molecular properties as found brain we re-analyzed publicly available single nuclear RNAseq datasets. Results Our analysis indicated that both decreased proportion differentiating into OL-lineage; consistent previous reports. now observe effect linked aberrant OPC differentiation. A subset O4+, reporter-positive expressed astrocytic marker Aquaporin-4 (AQP4). On transcriptomic level, acquire an astrocyte-like signature alongside conserved reactive phenotype. Analysis single- datasets revealed expressing signature. Discussion In context MS, these results imply present but inhibited along OL-lineage, acquiring stem-cell like phenotype, reducing capacity contribute towards repair. These help define potential for impaired myelin provide prospective route regenerative treatment.
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: June 5, 2024
Language: Английский
Citations
0